Skip to main content

Paroxetine (International)

In the US, Paroxetine (paroxetine systemic) is a member of the drug class selective serotonin reuptake inhibitors and is used to treat Anxiety, Anxiety and Stress, Body Dysmorphic Disorder, Borderline Personality Disorder, Depression, Dysautonomia, Excoriation Disorder, Generalized Anxiety Disorder, Hot Flashes, Intermittent Explosive Disorder, Major Depressive Disorder, Obsessive Compulsive Disorder, Panic Disorder, Persistent Depressive Disorder, Post Traumatic Stress Disorder, Postmenopausal Symptoms, Postpartum Depression, Premature Ejaculation, Premenstrual Dysphoric Disorder, Social Anxiety Disorder, Somatoform Pain Disorder, Trichotillomania and Vulvodynia.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AB05

CAS registry number (Chemical Abstracts Service)

0061869-08-7

Chemical Formula

C19-H20-F-N-O3

Molecular Weight

329

Therapeutic Category

Antidepressant: Selective serotonin reuptake inhibitor (SSRI)

Chemical Names

(-)-trans-4-(p-Fluorophenyl)-3-[[3,4-(metylenedioxy)phenoxy]metyl]-piperidine (WHO)

(3S-trans)-3-[(1,3-Benzodioxol-5-yloxy)metyl]-4-(4-fluorphenyl)piperidine

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs